Percutaneous Coronary Intervention for Left Main and Multivessel Coronary Artery Disease - A Review of Strategies

Login or register to view PDF.
Citation
ICR - Volume 7 Issue 2 - Autumn 2012;2012:7(2):86-90
DOI
http://dx.doi.org/10.15420/icr.2012.7.2.86

Abstract

Patients with complex and multivessel disease present challenging clinical problems in defining treatment strategies. The Synergy between PCI with taxus and cardiac surgery (SYNTAX) trial, which included both a randomised as well as a registry experience has clarified many issues. These include the extent and severity of the disease, the clinical presentation, and the metrics used for comparison. The development, validation and application of the SYNTAX score has been of fundamental importance. In those patients with the least complex coronary anatomy, using hard endpoints such as death and myocardial infarction, the outcomes of treatment with either percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG) are similar although repeat revascularisation rates remain higher with PCI. In those patients with more extensive and complex disease, coronary artery bypass remains the standard of care. It must be remembered that the drug-eluting stent tested in SYNTAX was a first generation device and that newer generations are safer and more effective. Perhaps the most important guidance in the field of treatment of complex multivessel coronary disease is the attention paid to the Heart Team concept wherein both interventional cardiologists and cardiovascular surgeons are strongly encouraged to work together in these patients to identify the optimal approach consistent with the patients needs and objectives.

To view the full article in PDF or eBook formats, please click on the icons above.

References
  1. Kushner FG, Hand M, Smith SC, Jr., et al., 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol , 2009;54:2205–41.
    Crossref | PubMed
  2. Taggart DP, Kaul S, Boden WE, et al., Revascularisation for unprotected left main stem coronary artery stenosis stenting or surgery, J Am Coll Cardiol , 2008;51:885–92.
    Crossref | PubMed
  3. Reig J PM, Main trunk of the left coronary artery: anatomic study of the parameters of clinical interest, Clin Anat (NY) , 2004;17:6–13.
    Crossref | PubMed
  4. Prosi M, Perktold K, Ding Z, Friedman MH, Influence of curvature dynamics on pulsatile coronary artery flow in a realistic bifurcation model, J Biomech , 2004;37:1767–75.
    Crossref | PubMed
  5. Topaz O, Warner M, Lanter P, et al., Isolated significant left main coronary artery stenosis: angiographic, hemodynamic, and clinical findings in 16 patients, Am Heart J , 1991;122:1308–14.
    Crossref | PubMed
  6. Morice MC, Serruys PW, Kappetein AP, et al., Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial, Circulation , 2010;121:2645–53.
    Crossref | PubMed
  7. Chieffo A, Park SJ, Valgimigli M, et al., Favorable long-term outcome after drug-eluting stent implantation in nonbifurcation lesions that involve unprotected left main coronary artery: a multicenter registry, Circulation , 2007;116:158–62.
    Crossref | PubMed
  8. Biondi-Zoccai GG, Lotrionte M, Anselmino M, et al., Systematic review and meta-analysis of randomized clinical trials appraising the impact of cilostazol after percutaneous coronary intervention, Am Heart J , 2008;155:1081–9.
    Crossref | PubMed
  9. Serruys PW, The synergy between percutaneous coronary intervention with Taxus and cardiac Surgery: thhe SYNTAX Study, Transcatheter Therapies Meeting November 8 2011.
  10. Min SY, Park DW, Yun SC, et al., Major predictors of long- term clinical outcomes after coronary revascularization in patients with unprotected left main coronary disease: analysis from the MAIN-COMPARE study, Circulation Cardiovasc Interv , 2010;3:127–33.
    Crossref | PubMed
  11. Capodanno D, Miano M, Cincotta G, et al., EuroSCORE refines the predictive ability of SYNTAX score in patients undergoing left main percutaneous coronary intervention, Am Heart J , 2010;159:103–9.
    Crossref | PubMed
  12. Nam CW, Mangiacapra F, Entjes R, et al., Functional SYNTAX score for risk assessment in multivessel coronary artery disease, J Am Coll Cardiol , 2011;58:1211–8.
    Crossref | PubMed
  13. Fisher LD, Judkins MP, Lesperance J, et al., Reproducibility of coronary arteriographic reading in the coronary artery surgery study (CASS), Cathet Cardiovasc Diagn , 1982;8:565–75.
    Crossref | PubMed
  14. Yamagishi M, Hongo Y, Goto Y, et al., Intravascular ultrasound evidence of angiographically undetected left main coronary artery disease and associated trauma during interventional procedures, Heart Vessels , 1996;11:262–8.
    Crossref | PubMed
  15. Abizaid AS, Mintz GS, Abizaid A, et al., One-year follow-up after intravascular ultrasound assessment of moderate left main coronary artery disease in patients with ambiguous angiograms, J Am Coll Cardiol , 1999;34:707-15.
    Crossref | PubMed
  16. Jasti V, Ivan E, Yalamanchili V, et al., Correlations between fractional flow reserve and intravascular ultrasound in patients with an ambiguous left main coronary artery stenosis, Circulation , 2004;110:2831–6.
    Crossref | PubMed
  17. Oviedo C, Maehara A, Mintz GS, et al., Intravascular ultrasound classification of plaque distribution in left main coronary artery bifurcations: where is the plaque really located?, Circulation , 2010;3:105–12.
    Crossref | PubMed
  18. Park SJ, Kim YH, Park DW, et al., Impact of intravascular ultrasound guidance on long-term mortality in stenting for unprotected left main coronary artery stenosis. Circulation Cardiovasc Interv , 2009;2:167–77.
    Crossref | PubMed
  19. Chaitman BR, Fisher LD, Bourassa MG, et al., Effect of coronary bypass surgery on survival patterns in subsets of patients with left main coronary artery disease. Report of the Collaborative Study in Coronary Artery Surgery (CASS), Am J Cardiol , 1981;48:765–77.
    Crossref | PubMed
  20. Hashimoto H, Isshiki T, Ikari Y, et al., Effects of competitive blood flow on arterial graft patency and diameter. Medium- term postoperative follow-up, J Thorac Cardiovasc Surg , 1996;111:399–407.
    Crossref | PubMed
  21. Bech GJ, Droste H, Pijls NH, et al., Value of fractional flow reserve in making decisions about bypass surgery for equivocal left main coronary artery disease, Heart , 2001;86:547–52.
    Crossref | PubMed
  22. Smith SC, Jr., Dove JT, Jacobs AK, et al., ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines)–executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty), J Am Coll Cardiol , 2001;37:2215–39.
    Crossref | PubMed
  23. Briguori C, Sarais C, Pagnotta P, et al., Elective versus provisional intra-aortic balloon pumping in high-risk percutaneous transluminal coronary angioplasty, Am Heart J , 2003;145:700–7.
    Crossref | PubMed
  24. Park SJ, Hong MK, Lee CW, et al., Elective stenting of unprotected left main coronary artery stenosis: effect of debulking before stenting and intravascular ultrasound guidance, J Am Coll Cardiol , 2001;38:1054–60.
    Crossref | PubMed
  25. Mehilli J, Kastrati A, Byrne RA, et al., Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease, J Am Coll Cardiol , 2009;53:1760–8.
    Crossref | PubMed
  26. Iakovou I, Schmidt T, Bonizzoni E, et al., Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents, JAMA , 2005;293:2126–30.
    Crossref | PubMed
  27. Palmerini T, Marzocchi A, Tamburino C, et al., Temporal pattern of ischemic events in relation to dual antiplatelet therapy in patients with unprotected left main coronary artery stenosis undergoing percutaneous coronary intervention, J Am Coll Cardiol , 2009;53:1176–81.
    Crossref | PubMed
  28. Silvestri M, Barragan P, Sainsous J, et al., Unprotected left main coronary artery stenting: immediate and medium-term outcomes of 140 elective procedures, J Am Coll Cardiol , 2000;35:1543–50.
    Crossref | PubMed
  29. Park SJ, Kim YH, Lee BK, et al., Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation, J Am Coll Cardiol , 2005;45:351–6.
    Crossref | PubMed
  30. Curzen N, Percutaneous coronary intervention in unprotected left main stem disease: the state of play, Heart , 2005;91(Suppl.3):iii39–41.
    Crossref | PubMed
  31. Chieffo A, Stankovic G, Bonizzoni E, et al., Early and mid-term results of drug-eluting stent implantation in unprotected left main, Circulation , 2005;111:791–5.
    Crossref | PubMed
  32. Gao RL, Xu B, Chen JL, et al., Immediate and long-term outcomes of drug-eluting stent implantation for unprotected left main coronary artery disease: comparison with bare- metal stent implantation, Am Heart J , 2008;155:553–61.
    Crossref | PubMed
  33. Han Y, Wang S, Jing Q, et al., Comparison of long-term efficacy of the paclitaxel-eluting stent versus the bare-metal stent for treatment of unprotected left main coronary artery disease, Am J Cardiol , 2009;103:194–8.
    Crossref | PubMed
  34. Hertting K, Harle T, Krause K, et al., Stenting of unprotected left main stem stenosis: results from a German single-centre registry, Exp Clin Cardiol , 2008;13:37–41.
    PubMed
  35. Kim YH, Park DW, Lee SW, et al., Long-term safety and effectiveness of unprotected left main coronary stenting with drug-eluting stents compared with bare-metal stents, Circulation , 2009;120:400–7.
    Crossref | PubMed
  36. Palmerini T, Marzocchi A, Tamburino C, et al., Two-year clinical outcome with drug-eluting stents versus bare-metal stents in a real-world registry of unprotected left main coronary artery stenosis from the Italian Society of Invasive Cardiology, Am J Cardiol , 2008;102:1463–8.
    Crossref | PubMed
  37. Schrale RG, van Gaal W, Channon KM, et al., Long-term outcomes of percutaneous coronary intervention for unprotected left main coronary artery disease, Int J Cardiol , 2008;130:185–9.
    Crossref | PubMed
  38. Tamburino C, Di Salvo ME, Capodanno D, et al., Are drug- eluting stents superior to bare-metal stents in patients with unprotected non-bifurcational left main disease? Insights from a multicentre registry, Eur Heart J , 2009;30:1171–9.
    Crossref | PubMed
  39. Tamburino C, Di Salvo ME, Capodanno D, et al., Comparison of drug-eluting stents and bare-metal stents for the treatment of unprotected left main coronary artery disease in acute coronary syndromes, Am J Cardiol , 2009;103:187–93.
    Crossref | PubMed
  40. Erglis A, Narbute I, Kumsars I, et al., A randomized comparison of paclitaxel-eluting stents versus bare-metal stents for treatment of unprotected left main coronary artery stenosis, J Am Coll Cardiol , 2007;50:491–7.
    Crossref | PubMed
  41. Pandya SB, Kim YH, Meyers SN, et al., Drug-eluting versus bare-metal stents in unprotected left main coronary artery stenosis a meta-analysis, JACC Cardiovasc Interv , 2010;3:602–11.
    Crossref | PubMed
  42. Lee JY, Park DW, Yun SC, et al., Long-term clinical outcomes of sirolimus- versus paclitaxel-eluting stents for patients with unprotected left main coronary artery disease: analysis of the MAIN-COMPARE (revascularization for unprotected left main coronary artery stenosis: comparison of percutaneous coronary angioplasty versus surgical revascularization) registry, J Am Coll Cardiol , 2009;54:853–9.
    Crossref | PubMed
  43. Lee SH, Ko YG, Jang Y, et al., Sirolimus- versus paclitaxel- eluting stent implantation for unprotected left main coronary artery stenosis, Cardiology , 2005;104:181–5.
    Crossref | PubMed
  44. Meliga E, Garcia-Garcia HM, Valgimigli M, et al., Impact of drug-eluting stent selection on long-term clinical outcomes in patients treated for unprotected left main coronary artery disease: the sirolimus vs paclitaxel drug-eluting stent for left main registry (SP-DELFT), Int J Cardiol , 2009;137:16–21.
    Crossref | PubMed
  45. Valgimigli M, Malagutti P, Aoki J, et al., Sirolimus-eluting versus paclitaxel-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: a combined RESEARCH and T-SEARCH long-term analysis, J Am Coll Cardiol , 2006;47:507–14.
    Crossref | PubMed
  46. Palmerini T, Sangiorgi D, Marzocchi A, et al., Ostial and midshaft lesions vs. bifurcation lesions in 1111 patients with unprotected left main coronary artery stenosis treated with drug-eluting stents: results of the survey from the Italian Society of Invasive Cardiology, Eur Heart J , 2009;30:2087–94.
    Crossref | PubMed
  47. Vaquerizo B, Lefevre T, Darremont O, et al., Unprotected left main stenting in the real world: two-year outcomes of the French left main taxus registry, Circulation , 2009;119:2349–56.
    Crossref | PubMed
  48. Iakovou I, Ge L, Colombo A, Contemporary stent treatment of coronary bifurcations, J Am Coll Cardiol , 2005;46:1446–55.
    Crossref | PubMed
  49. Palmerini T, Marzocchi A, Tamburino C, et al., Impact of bifurcation technique on 2-year clinical outcomes in 773 patients with distal unprotected left main coronary artery stenosis treated with drug-eluting stents, Circulation Cardiovasc Interv , 2008;1:185–92.
    Crossref | PubMed
  50. Biondi-Zoccai GG, Giraudi E, Moretti C, et al., Impact of routine angiographic follow-up after percutaneous coronary drug-eluting stenting for unprotected left main disease: the Turin Registry, Clin Res Cardiol , 2010;99:235–42.
    Crossref | PubMed
  51. Sheiban I, Sillano D, Biondi-Zoccai G, et al., Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents 70 restenotic cases from a cohort of 718 patients: FAILS (Failure in Left Main Study), J Am Coll Cardiol , 2009;54:1131–6.
    Crossref | PubMed